In a major article for Pharmaceutical Market Europe, SynaptixBio explains the science behind gene silencing technologyJan 301 min readRead our latest news about gene silencing in PME here.
Dan Williams discusses SynaptixBio’s history, status, and aspirations in a major interview for leading US biotech podcast RAREcast
Amy Sheridan-Hill, co-founder of the H-ABC Foundation, and Dan Williams in major Mirror story about hopes for new drug
Commentaires